Page last updated: 2024-10-28

hydroxyzine and Maculopapular Cutaneous Mastocytosis

hydroxyzine has been researched along with Maculopapular Cutaneous Mastocytosis in 2 studies

Hydroxyzine: A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.
hydroxyzine : A N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy)ethyl and (4-chlorophenyl)(phenyl)methyl groups respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Simon, RA1
Khanna, N1
D'Souza, P1

Other Studies

2 other studies available for hydroxyzine and Maculopapular Cutaneous Mastocytosis

ArticleYear
Treatment of systemic mastocytosis.
    The New England journal of medicine, 1980, Jan-24, Volume: 302, Issue:4

    Topics: Cimetidine; Cromolyn Sodium; Cyproheptadine; Drug Therapy, Combination; Guanidines; Histamine H1 Ant

1980
Urticaria pigmentosa (mastocytosis).
    Indian pediatrics, 1998, Volume: 35, Issue:3

    Topics: Child, Preschool; Histamine H1 Antagonists; Humans; Hydroxyzine; Remission, Spontaneous; Urticaria P

1998